| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
1 company
Mehra Anand is a Director at Aclaris Therapeutics, Inc.. Recent SEC Form 4 filings include 3 buys and 1 sell.
Estimated insider holdings value: $3.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2024 | ACRS Aclaris Therapeutics, Inc. | Director | Buy | 666,666 | $2.25 | $1,499,998.50 | +1,537% | -49.9% | -46.4% | |
| Oct 22, 2018 | ACRS Aclaris Therapeutics, Inc. | Director | Buy | 372,093 | $10.75 | $3,999,999.75 | +24.2% | - | - | |
| Jan 10, 2017 | ACRS Aclaris Therapeutics, Inc. | Director | Sell | 750,000 | $28.25 | $21,188,325.00 | -32.8% | - | - | |
| Oct 13, 2015 | ACRS Aclaris Therapeutics, Inc. | Director, 10% Owner | Buy | 409,090 | $11.00 | $4,499,990.00 | +21.8% | - | - |